Revenue grew 8.4% year over year and fell 78.2% sequentially. Margins improved from the previous quarter, suggesting stronger cost discipline and operational efficiency. Year-over-year earnings remained under pressure, showing that the recovery in profitability is still incomplete.
Revenue growth stayed positive, supporting a healthier topline trend.
Margins improved from last quarter, suggesting that cost controls are starting to offset topline weakness.
Investor focus is likely to remain on whether management can restore earnings momentum over coming quarters.
Revenue trend and year-over-year growth across recent reported quarterly periods.
Net income and net margin trend over recent reported quarterly periods.
Abbvie Inc reported $13.3B in revenue for Q1 2025, up 8.4% YoY and down 78.2% QoQ. Positive year-over-year growth suggests healthier revenue momentum.
Net income came in at $1.3B, down 6.1% YoY and up 5945.5% QoQ. Net margin was 9.6%. Sequential margin improvement suggests stronger operating discipline despite a mixed revenue environment.
Quick factual answers for this report. Need the why behind them? Ask the report assistant.
Abbvie Inc reported revenue of $13.3B in Q1 2025.
Abbvie Inc reported net income of $1.3B in Q1 2025.
Abbvie Inc's revenue increased by 8.4% year over year in Q1 2025.
Abbvie Inc's net margin was 9.6% in Q1 2025.
Compare this quarter with the previous earnings report.
Explore company profile, industry, and historical context.
View more quarterly financial trend pages for this company.
Financial data is sourced from company filings and internal processed earnings data.
YoY and QoQ values are derived from reported quarterly figures when not directly available.
This page is for informational purposes only and does not constitute investment advice.